STAT+: Roche gets a lung cancer win with its KRAS drug divarasib
One of the more impressive data sets at this year’s ESMO came from a Roche study of its drug divarasib, which treats lung cancer.
Lees bij STAT News · 26 oktober 2026 om 23:17
STAT+: Roche gets a lung cancer win with its KRAS drug divarasib
Alle berichten over deze gebeurtenis, automatisch gegroepeerd uit meerdere onafhankelijke bronnen.
Laatst bijgewerkt: 27 oktober 2026 om 00:30 · 7 artikelen · 1 bronnen
STAT+: Nonprofit Bon Secours Mercy Health strikes $5.7 billion deal for surgery center chain
The deal would make the Catholic system one of the largest operators of outpatient surgery centers.
Lees bij STAT News · 26 oktober 2026 om 21:54
STAT+: HHS relaxes security, transparency rules for health record software used by hospitals
The Trump administration removed several security, privacy and transparency requirements for vendors of EHR software.
Lees bij STAT News · 26 oktober 2026 om 21:16
STAT+: House lawmaker probes PBMs for ‘punitive’ audits of independent pharmacies
A House lawmaker is investigating whether the three largest PMS targeted independent pharmacies withretaliatory audits.
Lees bij STAT News · 26 oktober 2026 om 16:26
STAT+: GSK sees its return to cancer start to pay off
A decade ago, GSK was out of oncology. It could soon pick up approval for its sixth cancer drug.
Lees bij STAT News · 26 oktober 2026 om 16:20
STAT+: Merck ADC drug cut risk of death by one-third in advanced endometrial cancer
A Phase 3 trial of a targeted drug developed by Merck and China’s Kelun-Biotech cut by one-third the risk of death in patients with advanced endometrial cancer.
Lees bij STAT News · 26 oktober 2026 om 15:30
STAT+: Rising premiums, a sad Medicaid gathering, and a new fraud crackdown
The cost of health insurance is surging, and CMS presses ahead with a new fraud crackdown.
Lees bij STAT News · 26 oktober 2026 om 14:38